Published in Nephrol Dial Transplant on January 22, 2014
Proceedings from an international consensus meeting on posttransplantation diabetes mellitus: recommendations and future directions. Am J Transplant (2014) 0.94
New-onset diabetes mellitus after kidney transplantation: Current status and future directions. World J Diabetes (2015) 0.84
Emerging treatments for post-transplantation diabetes mellitus. Nat Rev Nephrol (2015) 0.84
Dipeptidyl peptidase IV inhibitor MK-0626 attenuates pancreatic islet injury in tacrolimus-induced diabetic rats. PLoS One (2014) 0.81
Role of dipeptidyl peptidase-4 inhibitors in new-onset diabetes after transplantation. Korean J Intern Med (2015) 0.77
Dysglycemia after renal transplantation: Definition, pathogenesis, outcomes and implications for management. World J Diabetes (2015) 0.76
Transplantation: sitagliptin-balancing cardiovascular risk, hyperglycaemia and safety. Nat Rev Nephrol (2014) 0.75
Cardiovascular risk after orthotopic liver transplantation, a review of the literature and preliminary results of a prospective study. World J Gastroenterol (2016) 0.75
Effect of valsartan on the incidence of diabetes and cardiovascular events. N Engl J Med (2010) 5.46
Effect of nateglinide on the incidence of diabetes and cardiovascular events. N Engl J Med (2010) 4.38
Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial. Lancet (2003) 4.19
Estimated GFR associates with cardiovascular risk factors independently of measured GFR. J Am Soc Nephrol (2011) 2.25
Limitations of hemoglobin A1c for the diagnosis of posttransplant diabetes mellitus. Transplantation (2015) 2.00
Association of albuminuria and cancer incidence. J Am Soc Nephrol (2008) 1.91
Fasting plasma glucose and glycosylated hemoglobin in the screening for diabetes mellitus after renal transplantation. Transplantation (2009) 1.79
Impact of genetic polymorphisms in cytomegalovirus glycoprotein B on outcomes in solid-organ transplant recipients with cytomegalovirus disease. Clin Infect Dis (2009) 1.64
Parathyroid hormone, but not vitamin D, is associated with the metabolic syndrome in morbidly obese women and men: a cross-sectional study. Cardiovasc Diabetol (2009) 1.62
Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival. Kidney Int (2004) 1.57
Short-term treatment with rosiglitazone improves glucose tolerance, insulin sensitivity and endothelial function in renal transplant recipients. Nephrol Dial Transplant (2004) 1.46
The impact of short-term ciclosporin A treatment on insulin secretion and insulin sensitivity in man. Nephrol Dial Transplant (2007) 1.43
Improved prediction of tacrolimus concentrations early after kidney transplantation using theory-based pharmacokinetic modelling. Br J Clin Pharmacol (2014) 1.38
Diagnosing PTDM. Transplantation (2002) 1.37
The impact of cytomegalovirus infection and disease on rejection episodes in renal allograft recipients. Am J Transplant (2002) 1.36
Comparing mycophenolate mofetil regimens for de novo renal transplant recipients: the fixed-dose concentration-controlled trial. Transplantation (2008) 1.34
Predictors of change in estimated GFR: a population-based 7-year follow-up from the Tromso study. Nephrol Dial Transplant (2008) 1.30
Albuminuria as risk factor for initiation and progression of carotid atherosclerosis in non-diabetic persons: the Tromsø Study. Eur Heart J (2006) 1.27
Improved Tacrolimus Target Concentration Achievement Using Computerized Dosing in Renal Transplant Recipients-A Prospective, Randomized Study. Transplantation (2015) 1.19
Insulin resistance after renal transplantation: the effect of steroid dose reduction and withdrawal. J Am Soc Nephrol (2004) 1.13
Inflammatory mediators in morbidly obese subjects: associations with glucose abnormalities and changes after oral glucose. Eur J Endocrinol (2009) 1.13
Assessment of renal allograft fibrosis by acoustic radiation force impulse quantification--a pilot study. Transpl Int (2010) 1.10
Clinical outcomes in elderly kidney transplant recipients are related to acute rejection episodes rather than pretransplant comorbidity. Transplantation (2009) 1.09
Overall and cardiovascular mortality in Norwegian kidney donors compared to the background population. Nephrol Dial Transplant (2011) 1.08
Acute renal failure early after heart transplantation: risk factors and clinical consequences. Clin Transplant (2010) 1.07
The clinical utility of whole blood versus plasma cytomegalovirus viral load assays for monitoring therapeutic response. Transplantation (2011) 1.07
CYP3A5 genotype is not associated with a higher risk of acute rejection in tacrolimus-treated renal transplant recipients. Pharmacogenet Genomics (2008) 1.07
Cytomegalovirus resistance in solid organ transplant recipients treated with intravenous ganciclovir or oral valganciclovir. Antivir Ther (2009) 1.05
Benefit of kidney transplantation beyond 70 years of age. Nephrol Dial Transplant (2009) 1.02
Low serum creatinine is associated with type 2 diabetes in morbidly obese women and men: a cross-sectional study. BMC Endocr Disord (2010) 1.01
A 6-year prospective study on new onset diabetes mellitus, insulin release and insulin sensitivity in renal transplant recipients. Nephrol Dial Transplant (2003) 1.01
Undiagnosed diabetes in kidney transplant candidates: a case-finding strategy. Clin J Am Soc Nephrol (2010) 1.01
Disturbances in beta-cell function in impaired fasting glycemia. Diabetes (2002) 1.01
Intermittent saline flushes during haemodialysis do not alleviate coagulation and clot formation in stable patients receiving reduced doses of dalteparin. Nephrol Dial Transplant (2005) 1.00
Incidence and outcomes of ganciclovir-resistant cytomegalovirus infections in 1244 kidney transplant recipients. Transplantation (2011) 1.00
Albuminuria and risk of nonvertebral fractures. Arch Intern Med (2007) 0.99
Uric acid is a risk factor for ischemic stroke and all-cause mortality in the general population: a gender specific analysis from The Tromsø Study. BMC Cardiovasc Disord (2013) 0.97
Early cyclosporine withdrawal from a sirolimus-based regimen results in better renal allograft survival and renal function at 48 months after transplantation. Transpl Int (2005) 0.97
Recurrent lupus nephritis after kidney transplantation: a surveillance biopsy study. Ann Rheum Dis (2010) 0.97
Serglycin is a major proteoglycan in polarized human endothelial cells and is implicated in the secretion of the chemokine GROalpha/CXCL1. J Biol Chem (2010) 0.96
Early posttransplant serum osteoprotegerin levels predict long-term (8-year) patient survival and cardiovascular death in renal transplant patients. J Am Soc Nephrol (2006) 0.95
Glycated hemoglobin level is strongly related to the prevalence of carotid artery plaques with high echogenicity in nondiabetic individuals: the Tromsø study. Circulation (2004) 0.94
The risk of living kidney donation. Nephrol Dial Transplant (2003) 0.94
Cyclosporine A- and tacrolimus-mediated inhibition of CYP3A4 and CYP3A5 in vitro. Drug Metab Dispos (2011) 0.94
Virologic suppression measured by a cytomegalovirus (CMV) DNA test calibrated to the World Health Organization international standard is predictive of CMV disease resolution in transplant recipients. Clin Infect Dis (2013) 0.92
Reduced incidence of new-onset posttransplantation diabetes mellitus during the last decade. Transplantation (2007) 0.92
Is there a link between cytomegalovirus infection and new-onset posttransplantation diabetes mellitus? Potential mechanisms of virus induced beta-cell damage. Nephrol Dial Transplant (2005) 0.92
Physical exercise, fasting glucose, and renal hyperfiltration in the general population: the Renal Iohexol Clearance Survey in Tromsø 6 (RENIS-T6). Clin J Am Soc Nephrol (2012) 0.91
The influence of CYP3A, PPARA, and POR genetic variants on the pharmacokinetics of tacrolimus and cyclosporine in renal transplant recipients. Eur J Clin Pharmacol (2014) 0.90
Fasting plasma glucose in the screening for type 2 diabetes in morbidly obese subjects. Obes Surg (2009) 0.90
Early versus late acute antibody-mediated rejection in renal transplant recipients. Transplantation (2013) 0.89
Long-term clinical outcome of paediatric kidneys transplanted to adults. Nephrol Dial Transplant (2008) 0.88
Kidney transplantation in the elderly--the Norwegian experience. Nephrol Dial Transplant (2007) 0.88
Importance of hematocrit for a tacrolimus target concentration strategy. Eur J Clin Pharmacol (2013) 0.88
Declining intracellular T-lymphocyte concentration of cyclosporine a precedes acute rejection in kidney transplant recipients. Transplantation (2008) 0.88
The impact of impaired insulin release and insulin resistance on glucose intolerance after renal transplantation. Clin Transplant (2002) 0.87
Diabetes: cost of illness in Norway. BMC Endocr Disord (2010) 0.87
Effect of fluvastatin on renal end points in the Assessment of Lescol in Renal Transplant (ALERT) trial. Kidney Int (2004) 0.87
Estimated GFR is biased by non-traditional cardiovascular risk factors. Am J Nephrol (2015) 0.87
Hypoadiponectinemia is associated with insulin resistance and glucose intolerance after renal transplantation: impact of immunosuppressive and antihypertensive drug therapy. Clin J Am Soc Nephrol (2006) 0.86
Determinants of short-term changes in body composition following renal transplantation. Scand J Urol Nephrol (2009) 0.86
Inclusion of CYP3A5 genotyping in a nonparametric population model improves dosing of tacrolimus early after transplantation. Transpl Int (2013) 0.86
Quantitative measurement of muscle fiber composition in a normal population. Muscle Nerve (2003) 0.85
Determinants of insulin secretion after renal transplantation. Metabolism (2003) 0.85
Aminated beta-1,3-D-glucan improves wound healing in diabetic db/db mice. Wound Repair Regen (2007) 0.85
Non-invasive assessment of renal allograft fibrosis by dynamic sonographic tissue perfusion measurement. Acta Radiol (2011) 0.84
A prospective study on size and function of paediatric kidneys (<10 years) transplanted to adults. Nephrol Dial Transplant (2007) 0.84
New-onset posttransplantation diabetes mellitus: insulin resistance or insulinopenia? Impact of immunosuppressive drugs, cytomegalovirus and hepatitis C virus infection. Curr Diabetes Rev (2005) 0.84
[Methanol poisoning in Norway 2002]. Tidsskr Nor Laegeforen (2004) 0.84
Plasma oxalate following kidney transplantation in patients without primary hyperoxaluria. Nephrol Dial Transplant (2010) 0.84
The impact of early cytomegalovirus infection after kidney transplantation on long-term graft and patient survival. Clin Transplant (2013) 0.83
High ficolin-3 level at the time of transplantation is an independent risk factor for graft loss in kidney transplant recipients. Transplantation (2015) 0.83
Anthropometric characteristics and type 2 diabetes in extremely obese Caucasian subjects: a cross-sectional study. Diabetes Res Clin Pract (2009) 0.82
Autoregulation of endogenous glucose production during hyperglucagonemia. Metabolism (2002) 0.82
Parathyroid hormone and clinical outcome in kidney transplant patients with optimal transplant function. Clin Transplant (2014) 0.82
Early posttransplantation hyperglycemia in kidney transplant recipients is associated with overall long-term graft losses. Transplantation (2012) 0.82
Aortic Stiffness in a Mortality Risk Calculator for Kidney Transplant Recipients. Transplantation (2015) 0.82
Risk variables associated with the outcome of kidney recipients >70 years of age in the new millennium. Nephrol Dial Transplant (2011) 0.82
Induction with interleukin-2 antagonist for transplantation of kidneys from older deceased donors: an observational study. Transplant Res (2013) 0.82
Glucose tolerance before and after renal transplantation. Nephrol Dial Transplant (2009) 0.82